LeClair Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

LeClair Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-397	Closed	-$230K	–	184
2025 Q4	$230K	Buy	+397	New	+$225K	0.13%	100
2025 Q2	–	Sell	-410	Closed	-$204K	–	103
2025 Q1	$204K	Sell	410 -21	-5%	-$11.4K	0.15%	94
2024 Q4	$224K	Buy	+431	New	+$237K	0.15%	90

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

LeClair Wealth Partners's TMO Position: Q1 2026 in Review

LeClair Wealth Partners sold out of Thermo Fisher Scientific (TMO) in Q1 2026, closing a stake of 397 shares — an estimated $230K sold.

LeClair Wealth Partners first reported a position in TMO in Q4 2024 and held it in 3 quarters. The position peaked at $230K in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

LeClair Wealth Partners reported no remaining Thermo Fisher Scientific position as of Q1 2026 after selling out during the quarter.
LeClair Wealth Partners sold 397 Thermo Fisher Scientific shares in Q1 2026, an estimated $230K.
LeClair Wealth Partners first reported a position in Thermo Fisher Scientific in Q4 2024 and held it in 3 quarters.
LeClair Wealth Partners's Thermo Fisher Scientific position peaked at $230K in Q4 2025.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on LeClair Wealth Partners's 13F filing for Q1 2026, filed 5 May 2026.